Investing
Investing Cash Flow
Pfizer Investing Cash Flow decreased by 152.9% to -$6.15B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -60.9% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.
Detailed definition
The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...
Peer comparison
Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.
Metric ID:
cf_net_cash_from_investingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.14B | -$10.08B | -$2.59B | $567.00M | -$11.31B | -$627.00M | -$4.41B | $3.32B | -$25.49B | $888.00M | -$11.00B | $1.73B | $4.60B | -$2.06B | $3.27B | $3.95B | -$2.43B | -$6.15B |
| QoQ Change | — | -23.8% | +74.3% | +121.9% | <-999% | +94.5% | -603.3% | +175.2% | -868.8% | +103.5% | <-999% | +115.8% | +165.6% | -144.7% | +259.2% | +20.7% | -161.5% | -152.9% |
| YoY Change | — | — | — | — | -39.0% | +93.8% | -70.5% | +484.7% | -125.3% | +241.6% | -149.3% | -47.8% | +118.0% | -331.6% | +89.0% | -14.1% | -18.1% | — |
Range-$25.49B – $4.60B
CAGR-6.4%
Avg YoY Growth+17.8%
Median YoY Growth-18.1%
Current Streak2 quarters decline
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Pfizer's investing cash flow?
- Pfizer (PFE) reported investing cash flow of -$6.15B in Q4 2025.
- What is the long-term trend for Pfizer's investing cash flow?
- Over 3 years (2021 to 2025), Pfizer's investing cash flow has grown at a -60.9% compound annual growth rate (CAGR), from -$22.55B to -$1.35B.
- What does investing cash flow mean?
- The total net change in cash resulting from buying and selling long-term assets and investments.